Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Critical Care Medicine|February 8, 2011
Critical care in resource-poor settings: lessons learned and future directionsElisabeth D Riviello, Stephen Letchford, Loice Achieng, et al.
Tuberculosis (Edinburgh, Scotland)|November 18, 2011
A quality assessment tool for tuberculosis control activities in resource limited settingsKatherine McQuade Billingsley, Nathaniel Smith, Rhett Shirley, et al.
BMC Research Notes|April 26, 2017
Isolated splenic tuberculosis with subsequent paradoxical deterioration: a case reportFrederick Wangai, Loice Achieng, George Otieno, et al.
Jac-Antimicrobial Resistance|July 5, 2021
Evaluation of the clinical practice of aminoglycoside use in paediatric patients in Kenya: findings and implications for lower-middle income countriesElias Joseph Onyango, Faith Okalebo, Margaret Oluka, et al.
Plos One|March 20, 2012
An observational cohort comparison of facilitators of retention in care and adherence to anti-eetroviral therapy at an HIV treatment center in KenyaLoice Achieng, Helen Musangi, Sharon Ong'uti, et al.
Plos One|June 23, 2023
High rates of kidney impairment among older people (≥ 60 years) living with HIV on first-line antiretroviral therapy at screening for a clinical trial in KenyaJeremy Penner, Loice Achieng Ombajo, Davies Otieno, et al.
Globalization and Health|April 4, 2025
Reserve antibiotics: overcoming limitations of evidence generated from regulatory approval trialsLorenzo Moja, Mohamed Abbas, Marlieke Ea de Kraker, et al.
The Pan African Medical Journal|January 15, 2020
Empyema necessitans due to aspergillus in a 3-year-old paediatric patient at a referral hospital in Nairobi, KenyaAnne-Marie Macharia, Loice Achieng Ombajo, Abdirahman Hashi Farah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 26, 2024
Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the 48-week Randomised Second-line Switch to Dolutegravir TrialLoice Achieng Ombajo, Jeremy Penner, Joseph Nkuranga, et al.
Plos One|December 17, 2013
The use of pill counts as a facilitator of adherence with antiretroviral therapy in resource limited settingsLoice Achieng, Helen Musangi, Katherine Billingsley, et al.
Pageof 3